H. Bestehorn

发表

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

F. Neumann, D. Trenk, A. Caputo, 2006, Journal of the American College of Cardiology.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, JAMA.

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003 .

Akutes Koronarsyndrom, Myokardinfarkt, instabile Angina pectoris

F. Neumann, H. Bestehorn, 2008 .

Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents.

F. Neumann, H. Bestehorn, M. Ferenc, 2010, American heart journal.

Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions

F. Neumann, H. Bestehorn, M. Ferenc, 2008, European heart journal.

CLINICAL RESEARCH Interventional Cardiology Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement

F. Neumann, D. Trenk, A. Caputo, 2006 .

Cytochrome P 450 2 C 19 681 G > A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents

M. Fromm, F. Neumann, D. Trenk, 2008 .

Previous cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting.

S. Marsch, C. Mueller, J. Hodgson, 2003, Journal of interventional cardiology.

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial.

F. Neumann, L. Lévai, P. Betz, 2004, Journal of the American College of Cardiology.

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

R. Füth, H. Bestehorn, S. Kullmann, 2009, BMC cardiovascular disorders.

Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement

F. Neumann, D. Trenk, W. Hochholzer, 2007, Thrombosis and Haemostasis.

' s response to reviews Title : Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

H. Bestehorn, S. Kullmann, G. Haltern, 2009 .

Predictors of Improved Renal Function After Percutaneous Stent-Supported Angioplasty of Severe Atherosclerotic Ostial Renal Artery Stenosis

F. Neumann, T. Zeller, H. Bestehorn, 2003, Circulation.

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

M. Fromm, F. Neumann, D. Trenk, 2008, Journal of the American College of Cardiology.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.

M. Fromm, F. Neumann, D. Trenk, 2010, Journal of the American College of Cardiology.

Perkutane koronare Intervention

H. Bestehorn, J. Petersen, 2004 .

The effect of simvastatin on progression of coronary artery disease. The Multicenter coronary Intervention Study (CIS).

H. Wieland, L. Kappenberger, P. Betz, 1997, European heart journal.

Time Dependence of Platelet Inhibition After a 600-mg Loading Dose of Clopidogrel in a Large, Unselected Cohort of Candidates for Percutaneous Coronary Intervention

F. Neumann, D. Trenk, W. Hochholzer, 2005, Circulation.

Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial.

C. Di Mario, M. Morice, C. Macaya, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size After Primary Percutaneous Catheter Intervention in Myocardial Infarction With and Without ST-Segment Elevation

F. Neumann, H. Bestehorn, M. Ferenc, 2005, Circulation.

Ultrasound-Guided Strategy for Provisional Stenting With Focal Balloon Combination Catheter: Results From the Randomized Strategy for Intracoronary Ultrasound-Guided PTCA and Stenting (SIPS) Trial

J. Hodgson, H. Roskamm, H. Bestehorn, 2000, Circulation.

Heparin induced extracorporeal IDL-precipitation (help) promotes regression (REG) in patients with familial hypercholesterolemia II (FH)

H. Gohlke, P. Betz, H. Roskamm, 1991 .

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

M. Fromm, F. Neumann, D. Trenk, 2008, Journal of the American College of Cardiology.

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

R. Füth, H. Bestehorn, S. Kullmann, 2009, BMC cardiovascular disorders.

Operator experience and long term outcome after percutaneous coronary intervention.

Martin Brutsche, Stephan Marsch, S. Marsch, 2003, The Canadian journal of cardiology.